
VERIGRAFT VERIGRAFT makes transplantation possible without the severe risks of immunosuppression, and uses regenerative medicine technology to address so far incurable diseases. Our personalized tissue-engineered transplants that do not necessitate immunosuppression. Fully biological transplants that can surpass synthetic grafts with regards to durability and resistance to infection. Preclinical development for our personalized tissue-engineered veins (P-TEV) is completed and successful clinical proof of concept exists. Ready to start clinical trials. Therapeutic Developer

VERIGRAFT

VERIGRAFT makes transplantation possible without the severe risks of immunosuppression, and uses regenerative medicine technology to address so far incurable diseases. Our personalized tissue-engineered transplants that do not necessitate immunosuppression. Fully biological transplants that can surpass synthetic grafts with regards to durability and resistance to infection. Preclinical development for our personalized tissue-engineered veins (P-TEV) is completed and successful clinical proof of concept exists. Ready to start clinical trials.

Therapeutic Developer